“MAAP: Your Roadmap to Medication Success – Stay on Track, Stay Healthy!”
The issue of medication non-adherence is deeply concerning, with serious health and economic implications. In the USA alone, poor adherence is believed to result in 125,000 deaths each year and incurs an estimated $100 billion in costs annually, much of which is attributed to chronic diseases.
Among self-report questionnaires, the morisky scales are the most trusted scales to assess the medication adherence, because of its good sensitivity, specificity as well as its ease of use.
Identify individuals most at risk for medication-related problems by:
- Assessing medication adherence as low, medium or high
- Identifying intentional or unintentional-domains
- Predicting risk of non-adherence through the five WHO dimensions.
- Developing personalized interventions
- Providing targeted education and support
- Monitoring progress and adjusting plan as needed
- Tracking adherence rates and patient outcomes
- Monitoring healthcare utilization and costs
- Evaluating effectiveness of interventions and care plans
By using the Morisky Scale, healthcare providers can identify high-risk patients, develop targeted interventions, and measure the impact on quality and cost.
ABOUT THE MORISKY SCALE
What is The Morisky Scale
Dr. Donald Morisky, a UCLA School of Public Health professor, developed the Morisky scale MMAS4 and MMAS8, or Morisky Medication Adherence Scales, considered the GOLD STANDARD to assessing medication adherence. The MMAS is a generic self-reported, medication-taking behavior scale that can be tailored to specific health issues (high blood pressure, diabetes, elevated cholesterol, HIV, contraception, etc.). The Morisky Medication Adherence Scales have been cited over 32,298 times in academic journals.
Who USES The Morisky Scale
Many of the biggest names in pharma like Novartis, Jannsen, Pfizer, and Abbvie trust our highly validated tools for developing and testing new medications. A critical aspect of ensuring the success of these medications is understanding patient adherence to prescribed regimens during clinical trials.
The Morisky Adherence Scales are routinely used by Hospitals for Chronic Care Management (CCM) services that are billed under CPT 99490 for chronically ill Medicare patients and include at least 20 minutes of non-face to face time directed by a physician or other qualified health care professional, per calendar month.
The Morisky Adherence Scales are routinely used by Hospitals for Chronic Care Management (CCM) services that are billed under CPT 99490 for chronically ill Medicare patients and include at least 20 minutes of non-face to face time directed by a physician or other qualified health care professional, per calendar month.
BACKGROUND OF THE MORISKY SCALE
History of the Morisky Medication Adherence Scales. The development of the MMAS is credited to Dr. Donald E. Morisky, whose work in adherence has influenced healthcare practices globally.
- 1983 - Dr. Donald Morisky’s results were first published in the American Journal of Public Health from his doctoral dissertation that focused on long term outcomes of 400 hypertensive patience who were given educational counseling on the importance of medication taking vs. a control group who were not given any counseling.
- 1983 - National Heart, Lung, and Blood Institute (NHLBI) recommended Dr Donald Morisky’s educational protocol to become standard medical practice in the clinical setting.
- 1986 - Creation of MGL: Medical Care Journal published results of the impact on educational interventions on behavioral change and the scale became the Morisky, Green, and Levine Medication Adherence Questionnaire MGL MAQ.
- 1986 - Creation of the MMAS-4: Morisky Medication Adherence Scale MMAS-4 was developed based on many focus group sessions with anti-tuberculosis medication patients to gain insights in patient responses to the MGL.
- 1993 - 1997 - Creation of the MMAS-8: Morisky Medication Adherence Scale MMAS-8 was developed on an NIH research grant where I was an external consultant at the Marin Luther King Drew Medical Center in Los Angeles. A great deal of effort has been put into the development of the MMAS-8 relative to medication taking behavior questions.
Dr. Morisky's Publications
https://ph.ucla.edu/faculty/morisky
Permission from Dr. Morisky MMAR, LLC dba adherence is required to use the copyrighted Morisky Scales (MMAS-4 and MMAS-8), the most commonly used validated measure of medication non-adherence. A license to use the Morisky scales can be obtained through MMAR, LLC, dba adherence [email protected]